To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open99
High100.09
Low99
Prev. Close99.14
Avg. Traded Price99.71
Volume684

MARKET DEPTH

info2
Total bid22,495.00
Total ask10,549.00
OrdersQtyBid
1299.72
11299.71
1999.62
1599.61
2699.53
AskQtyOrders
99.9212
99.9613
99.97224
99.9815
99.99436

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

99.002 hours ago
100.092 hours ago
arrow

LOWER/UPPER CIRCUITS

79.31
118.96
arrow
Bal Pharma Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
notePrice to Earning Ratio,is 21.88, lower than its sector PE ratio of 43.54.
noteInterest Coverage Ratio,is 1.88, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
notePromoter Pledges,are zero.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 5.45%
Net profit growth 5Y CAGR : 81.6%
Bal Pharma Limited is a leading Indian Pharmaceutical Company specializing in Prescription Drugs Branded Formulations APIs Generic & OTC products Intravenous Infusions and Bulk Drugs. It has a rich experience of 25 years in the International and Domestic operations. The company has 5 state of the art manufacturing facilities located pan India. The plants are approved by major International Regulatory Authorities like WHO-GMP ISO 9001-2008. It has DMF approvals for Ebastine and Gliclazide in Japan and European markets. DMF filed for Bepotastine in US FDA. The company is adequately backed with in-house R&D Clinical Research Regulatory and other back end capabilities.
personal

Grow your wealth with more research recommendations

+91